Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Signs Two Genotyping Agreements with USDA

NEW YORK, Oct. 6 (GenomeWeb News) - Genaissance Pharmaceuticals has signed two genotyping agreements with the US Department of Agriculture, the New Haven, Conn.-based company said today.

 

Under a cooperative agreement with the USDA's Agricultural Research Service, Genaissance will develop genotyping assays to determine the origin and parentage of cattle, based on the distribution of certain SNPs in different types of beef and dairy cattle. ARS plans to make these assays available.

 

Genaissance also won a contract from the USDA's Animal Plant Health and Inspection Service for genotyping services to determine the susceptibility of sheep to scrapie.

 

The company did not disclose financial terms of the agreements.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.